Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 5 Results from the Thrombolysis in Myocardial Infarction (TIMI) 14 trial. Comparison of 90-min accelerated tissue-type plasminogen activator (t-PA) with combination therapy using abciximab (abcix) and reduced-dose t-PA (15-mg bolus and 35-mg infusion over 60 min) (t-PA = tissue-type plasminogen activator). (Data from Antman et al. [57].)
|
